newsfilter
← Latest News
GlobeNewswire·

Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences

  • Sionna Therapeutics (NASDAQ: SION) announced management participation in fireside chats at two upcoming investor events.
  • The company will present at Guggenheim's 3rd Annual Healthcare Innovation Conference on Monday, November 9, 2026, at 10:30 a.m. ET.
  • Management will also present at Stifel's 2026 Healthcare Conference on Tuesday, November 10, 2026, at 8:40 a.m. ET.
  • Live webcasts for both events will be accessible via the Investors section of Sionna's website, with replays available post-event.
  • Sionna is a clinical-stage biopharmaceutical company developing novel medicines to improve cystic fibrosis transmembrane conductance regulator (CFTR) protein function.
  • The company's strategy involves directly stabilizing CFTR's nucleotide binding domain 1 (NBD1) to restore protein function for people living with CF.
  • Sionna uses its Investor Relations website to disclose material nonpublic information & comply with Regulation FD.